• Sections
  • Newsletters
  • Podcasts
  • Support TPM
  • Shop Merch
  • Site Info
  • About
  • Sections
  • Editors' Blog
  • News
  • Live Blog
  • Cafe
  • Muckraker
  • Morning Memo
  • Where Things Stand
  • The Weekender
  • Features
  • Support TPM
  • Memberships
  • The TPM Journalism Fund
  • Site Info
  • FAQ
  • Contact
  • Advertise
  • Terms
  • Privacy
  • Site Status
  • About
  • About TPM
  • Mission
  • Masthead
  • Financials
  • Careers
  • Pitch Us
Follow TPM
© 2026 TPM MEDIA LLC. ALL RIGHTS RESERVED.
Talking Points Memo Logo
Send Tips TPM 25th Anniversary Badge
FDA
FDA Yanks Emergency Authorization For Hydroxychloroquine
By Matthew Perrone
06.15.20 | 12:06 pm
Citing Heart Problems, FDA Calls For Limiting Use Of Antimalarial Drugs Trump Championed
By Matt Shuham
04.24.20 | 12:22 pm
A Top Government Scientist Sends A Sharp Warning About ‘Politicized’ COVID-19 Work
By Matt Shuham
04.23.20 | 5:17 pm
FDA Commissioner: ‘Too Early’ To Say Whether Economy Should Reopen In May
By Summer Concepcion
04.12.20 | 1:55 pm
NANTONG, CHINA - FEBRUARY 27 2020: Employees work on the production line of chloroquine phosphate, resumed after a 15-year break, in a pharmaceutical company in Nantong city in east China's Jiangsu province Thursday, Feb. 27, 2020. Chloroquine phosphate, an old drug for the treatment of malaria, has shown some efficacy and acceptable safety against COVID-19 associated pneumonia in trials, according to Chinese media. NANTONG, CHINA - FEBRUARY 27 2020: Employees work on the production line of chloroquine phosphate, resumed after a 15-year break, in a pharmaceutical company in Nantong city in east China's Jiangsu province Thursday, Feb. 27, 2020. Chloroquine phosphate, an old drug for the treatment of malaria, has shown some efficacy and acceptable safety against COVID-19 associated pneumonia in trials, according to Chinese media.
FDA Gives Emergency Authorization To Potential COVID-19 Drugs, But Doubts Remain
By Matt Shuham
03.30.20 | 6:07 pm
The Bucks Stops Over There Somewhere: Trump Refuses To Own COVID-19 Failures
By Matt Shuham
03.13.20 | 5:43 pm
Head Of National Cancer Institute Will Temporarily Take Over FDA
By Matthew Perrone
03.12.19 | 2:57 pm
FDA Commissioner Resigns After Nearly Two Years Leading Agency
By Matthew Perrone
03.05.19 | 3:32 pm
Next →
Talking Points Memo
© 2026 TPM MEDIA LLC.
Masthead Contact Privacy Policy
  • About
  • Memberships
  • Careers
  • Advertise
  • Site Status
  • FAQ
  • Newsletters
  • Pitch Us
  • Terms of Use
  • CCPA Notice